본문 바로가기
주메뉴 바로가기
뉴로바이오젠
ABOUT
Overview
History
CI
Affiliate Company
This is the way
BUSINESS
Vision & Motto
Pipeline
Tisolagiline(KDS2010)
COMMUNICATIONS
News
Announcements
R&D
Corporate R&D Center
Joint research Institute
IR
Announcement
Corporate Disclosure
CAREERS
Ideal Candidate
Employment Announce
ENG
KOR
ENG
COMMUNICATION
News
Announcements
News & Press Release
Neurobiogen "Development of an innovative obesity drug that loses weight by eating without yo-yo and
DATE : 2023-09-07
VIEWS : 2576
FILES
PREV
Obesity, diabetes medicine that can't be sold because it's not there...Pharmaceutical Bio to Develop
NEXT
Losing weight while eating?What is the principle of the new drug candidate 'KDS2010'?
LIST
Add
(06714) 2 FL, Bangbae BLDG, 9, Myeongdal-ro, Seocho-gu, Seoul, Republic of Korea
Tel
+82-70-4018-8009
Fax
+82-02-3486-2613
E-mail
neuro_reply@neurobiogen.com
FAMILY SITE
(주)시너지이노베이션
(주)메디카코리아
(주)프로톡스
(주)인트로바이오파마
(주)엠아이텍
노비스바이오(주)
COPYRIGHT ⓒ 2025 NEUROBIOGEN. All rights reserved